Share Email Print
cover

Proceedings Paper

Summary of combined treatment under endoscope on 70 esophagus cancer inpatients
Author(s): Cheng Wang; Meilong Nong; Laisheng Li; Fang Jia; Runchun Hao
Format Member Price Non-Member Price
PDF $14.40 $18.00

Paper Abstract

We announce with satisfaction that combined treatment on 70 inpatients who suffered esophageal cancer in its middle or late course is perfectly successful. The combined methods include phototherapy, microwave therapy, and anticarcinogen local injection. The results are as follows: CR 3 cases, holds 4.3% of the total inpatients; PR 36 cases, 51.4%; MR 24 cases, 34.3%; NR 7 cases, 10%; the total effective rate 90%. Splendid results of treatment on enlarging the canal, improving dysphagia, and releasing obstruction have been obtained. The dysphagic grade increased from 66 to 148, the grade of esophagostenosis from 64 to 147, and the obstruction releasing rate is 69 out of 70 (that is 98.6%). The histological observation after treatment shows that 59/62 inpatients being reported as having cancer cells appear to have retrogression accompanied with a few or large quantities of necrotic cancer cells, and 3 inpatients were changed to negative reaction. No obvious poisoning or side effects arose. The combined treatment is more advantageous on those of old age or the physically weak and those who cannot stand for an operation, radiotherapy, or normal chemotherapy.

Paper Details

Date Published: 5 March 1993
PDF: 4 pages
Proc. SPIE 1616, International Conference on Photodynamic Therapy and Laser Medicine, (5 March 1993); doi: 10.1117/12.136962
Show Author Affiliations
Cheng Wang, Armed Police Henan General Hospital (China)
Meilong Nong, Armed Police Henan General Hospital (China)
Laisheng Li, Armed Police Henan General Hospital (China)
Fang Jia, Armed Police Henan General Hospital (China)
Runchun Hao, Armed Police Henan General Hospital (China)


Published in SPIE Proceedings Vol. 1616:
International Conference on Photodynamic Therapy and Laser Medicine

© SPIE. Terms of Use
Back to Top